Armistice Capital, Llc - Dec 31, 2024 SCHEDULE 13G/A Report for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol: SUPN
Shares outstanding: 55.2M shares
Disclosed Ownership: 4.84M shares
Ownership: 8.76%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 05:20 PM
Date of event: Dec 31, 2024
Next filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	8.76%	4.84M	0	4.84M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	8.76%	4.84M	0	4.84M	/s/ Steven Boyd	Steven Boyd